Top Markets
Coin of the day
Natural Beauty Bio-Technology Limited Natural Beauty Bio-Technology Limited

Natural Beauty Bio-Technology Limited

0157
Rank in Stocks #20911
Natural Beauty Bio-Technology Limited operates as an investment holding... Natural Beauty Bio-Technology Limited operates as an investment holding company, supplying skincare products and a comprehensive range of services across the People's Republic of China, Taiwan, and other global regions. Under its "Natural Beauty" brand, the firm develops and sells a diverse array of items, including skincare, beauty, aromatherapy goods, cosmetics, health supplements, and makeup. Complementing its product line, the company delivers professional services such as skin treatments, spa and beauty therapies, medical aesthetic procedures, alongside expert consulting and training in skincare and general beauty. Its network of spas further enhances these offerings with hydrotherapy, specialized facial treatments, holistic body care, and detailed skin analysis. Furthermore, the company is involved in the wholesale distribution of its beauty and skincare merchandise. Established in 1976, Natural Beauty Bio-Technology Limited is headquartered in Wan Chai, Hong Kong.
Share Price
$0.0594857
Last synced: 2026-08-21
Market Cap
$119.10M
Change (1 day)
2.20%
Change (1 year)
-16.99%
Country
HK
Trade Natural Beauty Bio-Technology Limited (0157)
Earnings for Natural Beauty Bio-Technology Limited (0157)
Earnings in 2026 TTM: 0
According to Natural Beauty Bio-Technology Limited latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Natural Beauty Bio-Technology Limited from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$20.38B -
US
$9.83B -
FR
$2.94B -
US
$1.55B -
IN
- -
DE